For the Inventor, By the Inventor

Enter assignee name

Takara Bio Inc.

USPTO Granted Patents = 147

CIPO Patents = 3

EPO Patents = 41

Trademarks = 20

Forward Citations = 481

Loading Chart...

Loading Chart...

225 inventors (with patents filed for the assignee):

Ikunoshin Kato (85 out of 210 patents)

Takashi Uemori (32 out of 43 patents)

Junichi Mineno (28 out of 28 patents)

4. Hiroaki Sagawa (27 out of 45 patents)

5. Kiyozo Asada (22 out of 47 patents)

6. Tatsuji Enoki (21 out of 33 patents)

7. Hiroyuki Mukai (20 out of 29 patents)

8. Hiroshi Shiku (12 out of 21 patents)

9. Hikaru Takakura (12 out of 15 patents)

10. Takeshi Sakai (11 out of 51 patents)

11. Nobuto Koyama (10 out of 37 patents)

12. Eiji Kobayashi (9 out of 36 patents)

13. Hideto Chono (9 out of 12 patents)

14. Yoshimi Sato (9 out of 12 patents)

15. Jun Tomono (9 out of 14 patents)

Core Competencies:

AAV Mutant

DNA Polymerase Variant

Chimeric Antigen Receptors

Nucleic Acid Amplification

Stem Cell Production

Endothelial Cells

Heat-Resistant Enzymes

Viral Vector Production

Cytotoxic T Lymphocyte

Pluripotent Stem Cells

Nucleic Acid Synthesis

Natural Killer Cells

147 patents: Sort by Forward Citations

1. 12421526 - AAV mutant having brain-targeting property (2025-09-23),

2. 12359177 - DNA polymerase mutant suited to nucleic acid amplification from RNA (2025-07-15),

3. 12018294 - DNA polymerase mutant suited to nucleic acid amplification from RNA (2024-06-25),

4. 12018276 - Lymphocyte production method (2024-06-25),

5. 11999972 - Fibronectin fragment to be used for stem cell production (2024-06-04),

6. 11572580 - Oligonucleotide preservation method (2023-02-07),

7. 11473057 - Method for obtaining microglia from pluripotent stem cells (2022-10-18),

8. 11225643 - Method for producing endothelial cells (2022-01-18),

9. 11220677 - Heat-resistant reverse transcriptase mutant (2022-01-11),

10. 11046939 - DNA polymerase variant (2021-06-29),

11. 11028131 - Mutant of adeno-associated virus (AAV) capsid protein (2021-06-08),

12. 10975415 - Methods of utilizing thermostable mismatch endonuclease (2021-04-13),

13. 10822392 - Nucleic acids comprising polynucleotides encoding chimeric antigen receptors (2020-11-03),

14. 10760074 - Composition for detection of RNA (2020-09-01),

15. 10731226 - Method for quantifying adeno-associated virus (2020-08-04),

TAKARA BIO INC. is a leading biotechnology company specializing in the development and commercialization of innovative tools and technologies for life science research and healthcare. With a wide range of products and services, we strive to support scientists and healthcare professionals worldwide in their quest for new discoveries and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

147 Patents

#1 in Kusatsu

#847 in Japan

#5,406 in the World

Takara Bio Inc.

Forward Citations = 481

225 inventors:

Ikunoshin Kato (85 out of 210 patents)

Takashi Uemori (32 out of 43 patents)

Junichi Mineno (28 out of 28 patents)

4. Hiroaki Sagawa (27 out of 45 patents)

5. Kiyozo Asada (22 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…